Multicenter prospective single-group study of three-day regimen of oseltamivir (Tamiflu) for postexposure prophylaxis.
Phase of Trial: Phase IV
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 19 Apr 2017 Status changed from not yet recruiting to recruiting.
- 03 Nov 2016 New trial record